Tumor Seeding Occurring after Fine-Needle Biopsy of Abdominal Malignancies

1991 ◽  
Vol 32 (6) ◽  
pp. 518-520 ◽  
Author(s):  
C. Lundstedt ◽  
H. Stridbeck ◽  
R. Andersson ◽  
K.-G. Tranberg ◽  
Å. Andrén-Sandberg
Keyword(s):  
Needle Biopsy ◽  
Diagnostic Procedure ◽  
Fine Needle Aspiration Biopsy ◽  
Radical Surgery ◽  
Fine Needle Biopsy ◽  
Needle Aspiration ◽  
High Accuracy ◽  
Tumor Seeding ◽  
Fine Needle ◽  
Choice Of Therapy

Percutaneous fine-needle aspiration biopsy is a commonly used diagnostic procedure with a high accuracy and a low complication rate. However, tumor seeding in the biopsy tracts has been recorded with a frequency of one in 20 000–40 000 biopsies. We report 5 cases of percutaneous tumor seeding recorded after 5 000 fine-needle biopsies of abdominal malignancies at our institution. The risk of implantation metastases induced by fine-needle biopsy warrants consideration in patients with abdominal malignancies since it may compromise the outcome of radical surgery. It should only be performed when the result of the procedure has a direct impact on the choice of therapy.

Time and Cost of Ultrasound-Guided Fine-Needle Aspiration Biopsy/Core-Needle Biopsy for Primary Laryngohypopharyngeal Squamous Cell Carcinoma

2020 ◽  
pp. 019459982094595
Author(s):  
Dongbin Ahn ◽  
Gil Joon Lee ◽  
Jin Ho Sohn
Keyword(s):  
Squamous Cell Carcinoma ◽  
Fine Needle Aspiration ◽  
Needle Biopsy ◽  
Fine Needle Aspiration Biopsy ◽  
Needle Aspiration ◽  
Ultrasound Guided ◽  
Core Needle ◽  
Fine Needle ◽  
Biopsy Core ◽  
The Us

Objectives This study aimed to evaluate benefits in terms of time and cost of percutaneous ultrasound-guided fine-needle aspiration biopsy/core-needle biopsy (US-FNAB/CNB) for the diagnosis of primary laryngeal and hypopharyngeal squamous cell carcinoma (LHSCC) in comparison with direct laryngoscopic biopsy (DLB) under general anesthesia. Study Design Retrospective case-control study. Setting Single operator of a single center. Subjects and Methods From 2018 to 2019, 28 patients who underwent percutaneous US-FNAB/CNB for the diagnosis of untreated LHSCC were enrolled. All US-FNAB/CNBs were performed in the outpatient department by a single head and neck surgeon. Their results were compared with those of 27 patients who underwent DLB under general anesthesia. Results No major complications occurred in the US-FNAB/CNB and DLB groups. Time to biopsy, time to pathologic diagnosis, and time to treatment initiation in the US-FNAB/CNB and DLB groups were 0 and 14 days ( P < .001), 7 and 20 days ( P < .001), and 24 and 35 days ( P = .001), respectively. Procedure-related costs were $368.5 and $981.0 in the US-FNAB/CNB and DLB groups ( P < .001). Conclusions US-FNAB/CNB offers true benefits in terms of time and cost over those given by conventional DLB for diagnosis of LHSCC in indicated patients.

Sign in / Sign up

Export Citation Format

Share Document